Skip to content

13F-HR filed by Column Group LLC

Column Group LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 7 holding rows worth $451,820,000.

Accession
0000950123-22-012332
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 7 entries on the cover page, a total value of $451,820,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $451,820,000 with VALUE read as thousands by filing date, 13F file number 028-20797. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NGM BIOPHARMACEUTICALS INC62921N105COM18,136,735$237,228,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock4,577,840$90,275,000thousands by filing date
RAPT THERAPEUTICS INC75382E109COM2,680,458$64,492,000thousands by filing date
TENAYA THERAPEUTICS INC87990A106COM9,400,290$27,261,000thousands by filing date
Surrozen, Inc.86889P109COM9,248,129$18,681,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM3,568,181$11,418,000thousands by filing date
EFFECTOR THERAPEUTICS INC28202V108COM4,309,329$2,465,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-22-012332this filing2022-11-14acceptance time not in the bulk data set